• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年12月至2022年3月中国香港特别行政区与新加坡新冠疫苗接种覆盖率与病死率之间的关联:一项比较研究

Association Between COVID-19 Vaccination Coverage and Case Fatality Ratio: a Comparative Study - Hong Kong SAR, China and Singapore, December 2021-March 2022.

作者信息

He Guanhao, Zhu Sui, Fu Di, Xiao Jianpeng, Zhao Jianguo, Lin Ziqiang, Liu Tao, Liang Xiaofeng, Ma Wenjun

机构信息

Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou City, Guangdong Province, China.

Disease Control and Prevention Institute, Jinan University, Guangzhou City, Guangdong Province, China.

出版信息

China CDC Wkly. 2022 Jul 29;4(30):649-654. doi: 10.46234/ccdcw2022.140.

DOI:10.46234/ccdcw2022.140
PMID:36062069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9433760/
Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Hong Kong Special Administrative Region (SAR), China and Singapore are both facing considerable Omicron variant epidemic. However, the overwhelmed medical system and high case fatality ratio (CFR) just occurred in Hong Kong SAR, China but not in Singapore.

WHAT IS ADDED BY THIS REPORT?: The low vaccination coverage in Hong Kong SAR, China, especially among the older adults, is shown to be a primary reason of its recent high CFR.

WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Facing the potential epidemic risk, non-vaccinated, non-fully-vaccinated, and non-booster-vaccinated people in China, especially the elderly, should get any type of accessible vaccine, which could save lives when the infection unfortunately befalls.

摘要

关于该主题已知的信息有哪些?:中国香港特别行政区(香港特区)和新加坡都面临着相当严重的奥密克戎变异株疫情。然而,医疗系统不堪重负和高病死率仅在中国香港特区出现,而新加坡并未出现。

本报告新增了哪些内容?:事实表明,中国香港特区疫苗接种覆盖率低,尤其是老年人中的覆盖率低,是其近期高病死率的主要原因。

对公共卫生实践有哪些启示?:面对潜在的疫情风险,中国未接种疫苗、未全程接种疫苗和未接种加强针的人群,尤其是老年人,应接种任何可及的疫苗,一旦不幸感染,这可能会挽救生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8978/9433760/198f8daea1f7/ccdcw-4-30-649-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8978/9433760/198f8daea1f7/ccdcw-4-30-649-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8978/9433760/198f8daea1f7/ccdcw-4-30-649-1.jpg

相似文献

1
Association Between COVID-19 Vaccination Coverage and Case Fatality Ratio: a Comparative Study - Hong Kong SAR, China and Singapore, December 2021-March 2022.2021年12月至2022年3月中国香港特别行政区与新加坡新冠疫苗接种覆盖率与病死率之间的关联:一项比较研究
China CDC Wkly. 2022 Jul 29;4(30):649-654. doi: 10.46234/ccdcw2022.140.
2
COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.2022年1月6日至2022年3月21日中国香港特别行政区的新冠病毒病死亡率及疫苗接种率
China CDC Wkly. 2022 Apr 8;4(14):288-292. doi: 10.46234/ccdcw2022.071.
3
The impact of COVID-19 vaccination campaign in Hong Kong SAR China and Singapore.2019冠状病毒病疫苗接种计划对中国香港特别行政区和新加坡的影响。
Infect Dis Model. 2023 Mar;8(1):101-106. doi: 10.1016/j.idm.2022.12.004. Epub 2022 Dec 20.
4
COVID-19 outbreaks in residential care homes in Hong Kong and effectiveness of vaccine against severe outcomes.香港安老院舍的2019冠状病毒病疫情及疫苗预防严重后果的有效性
Infect Med (Beijing). 2023 Mar;2(1):1-10. doi: 10.1016/j.imj.2023.01.002. Epub 2023 Jan 14.
5
Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study.香港新冠疫情各波次中COVID-19防控与传播的比较:一项观察性研究
Lancet Reg Health West Pac. 2023 Nov 22;43:100969. doi: 10.1016/j.lanwpc.2023.100969. eCollection 2024 Feb.
6
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants - China, May 21, 2021-February 28, 2022.2021年5月21日至2022年2月28日中国新冠病毒德尔塔或奥密克戎变异株感染患者的新冠病毒疫苗接种情况与临床严重程度的关联
China CDC Wkly. 2022 Apr 8;4(14):293-297. doi: 10.46234/ccdcw2022.074.
7
Hospital Strain and COVID-19 Fatality - England, April 2020-March 2022.医院毒株与新冠死亡病例——英格兰,2020年4月至2022年3月
China CDC Wkly. 2022 Dec 30;4(52):1176-1180. doi: 10.46234/ccdcw2022.236.
8
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.在香港,60 岁及以上人群中使用灭活全病毒 COVID-19 疫苗(科兴疫苗)的安全性:一项修改后的自身对照病例系列研究。
Lancet Healthy Longev. 2022 Jul;3(7):e491-e500. doi: 10.1016/S2666-7568(22)00125-8. Epub 2022 Jul 4.
9
Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study.西太平洋和东南亚六个国家及地区新冠病毒灭活疫苗的经济学评估:一项建模研究
Infect Dis Model. 2022 Mar;7(1):109-121. doi: 10.1016/j.idm.2021.12.002. Epub 2021 Dec 10.
10
Characterizing Human Collective Behaviors During COVID-19 - Hong Kong SAR, China, 2020.2020年中国香港特别行政区新冠疫情期间人类集体行为特征分析
China CDC Wkly. 2023 Jan 27;5(4):71-75. doi: 10.46234/ccdcw2023.014.

引用本文的文献

1
Suicide in Hong Kong during the COVID-19 pandemic: an observational study.香港在新冠疫情期间的自杀情况:一项观察性研究。
BMJ Public Health. 2024 Jul 20;2(1):e001125. doi: 10.1136/bmjph-2024-001125. eCollection 2024 Jun.
2
The effect of the COVID-19 pandemic on the trends and characteristics of natural and unnatural deaths in an urban Sri Lankan cohort viewed through retrospective analysis of forensic death investigations from 2019 to 2022.通过对2019年至2022年法医死亡调查的回顾性分析,观察新冠疫情对斯里兰卡一个城市队列中自然死亡和非自然死亡趋势及特征的影响。
Osong Public Health Res Perspect. 2023 Dec;14(6):468-482. doi: 10.24171/j.phrp.2023.0175. Epub 2023 Nov 23.
3

本文引用的文献

1
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
2
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.皮下注射卡司瑞韦单抗和伊德维单抗抗体组合与安慰剂对早期无症状 SARS-CoV-2 感染后出现有症状 COVID-19 的影响:一项随机临床试验。
JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939.
3
Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China.
帕罗韦德在中国降低重症 COVID-19 和死亡率的成本效益。
Front Public Health. 2023 Jun 19;11:1174879. doi: 10.3389/fpubh.2023.1174879. eCollection 2023.
4
The effectiveness of COVID-19 vaccination against all-cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the "Dynamic Zero Policy" in mainland China.COVID-19 疫苗接种对 2 型糖尿病患者全因死亡率的有效性:中国大陆“动态清零政策”取消初期的观察。
Diabetes Res Clin Pract. 2023 Jun;200:110694. doi: 10.1016/j.diabres.2023.110694. Epub 2023 May 8.
5
The factors correlated with COVID-19 vaccination coverage in Chinese hypertensive patients managed by community general practitioner.社区全科医生管理的中国高血压患者中与 COVID-19 疫苗接种率相关的因素。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2197839. doi: 10.1080/21645515.2023.2197839. Epub 2023 Apr 4.
6
The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.SARS-CoV-2 奥密克戎及其亚谱系的体液和细胞免疫逃逸。
Virol Sin. 2022 Dec;37(6):786-795. doi: 10.1016/j.virs.2022.11.007. Epub 2022 Nov 23.
SARS-CoV-2, COVID-19 and the Ageing Immune System.
SARS-CoV-2、COVID-19 和衰老的免疫系统。
Nat Aging. 2021 Sep;1(9):769-782. doi: 10.1038/s43587-021-00114-7. Epub 2021 Sep 14.
4
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.巴西在与伽马变异株相关的新冠疫情中,科兴疫苗对老年人的有效性:一项基于病例对照研究的核酸阴性结果研究。
BMJ. 2021 Aug 20;374:n2015. doi: 10.1136/bmj.n2015.